Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 29, 2023	Dec. 30, 2022
Cash Flows From Operating Activities
Net (loss) income	$ (2,286)	$ 2,907
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Stock-based compensation	2,062	2,295
Depreciation and amortization	17,121	15,979
Equity in earnings of unconsolidated joint ventures	(10,354)	(52,471)
Return on investments in unconsolidated joint ventures	14,682	59,651
Gain on sale of assets	(31,834)	0
Other	(47)	9,462
Changes in operating assets and liabilities:
Accounts receivable, net	2,251	41,574
Due from unconsolidated joint ventures	313	7,079
Contract assets	(9,334)	(46,736)
Accounts payable	13,747	10,436
Contract liabilities	(47,940)	(94,165)
Accrued expenses	(26,861)	31,471
Accrued salaries, wages and benefits	(8,975)	4,149
Other assets and liabilities	(645)	5,285
Net cash used in operating activities	(88,100)	(3,084)
Cash Flows From Investing Activities
Net working capital settlement in association with business combination	0	32,000
Purchases of property, plant and equipment	(7,042)	(10,443)
Proceeds from sale of assets	35,975	1,722
Unconsolidated joint venture equity contributions	(23,170)	(19,709)
Return of investments in unconsolidated joint ventures	16,287	627
Net cash provided by investing activities	22,050	4,197
Cash Flows From Financing Activities
Payments on finance lease obligation	(303)	(303)
Net borrowings on revolving credit facility	29,915	0
Contributions from noncontrolling interests	301	0
Distributions to non-controlling interests	(260)	(628)
Proceeds from IPO	25,025	0
Payments of IPO costs	(5,961)	0
Other	(842)	0
Net cash provided by (used in) financing activities	47,875	(931)
Net (decrease) increase in cash, cash equivalents and restricted cash	(18,175)	182
Cash, cash equivalents and restricted cash, beginning of period	82,085	81,903
Cash, cash equivalents and restricted cash, end of period	63,910	82,085
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	62,939	77,762
Restricted cash	971	4,323
Total cash, cash equivalents and restricted cash	$ 63,910	$ 82,085